Posizioni attive di Jens M. Kelm
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
InSphero AG
 InSphero AG BiotechnologyHealth Technology InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland. | Presidente | 26/03/2009 | - |
| Direttore Tecnico/Scientifico/R&S | 17/06/2013 | - | |
| Fondatore | 26/03/2009 | - | |
PreComb Therapeutics AG
 PreComb Therapeutics AG Pharmaceuticals: MajorHealth Technology PreComb Therapeutics AG is a Swiss company that specializes in functional precision medicine for oncology and cancer. The company is based in Hombrechtikon, Switzerland. The company uses organoid and predictive technologies, as well as AI and data mining, to guide therapy and automate processes. The company also works in immune oncology and collaborate with other organizations such as 2curex, Xilis, USZ, DKFZ, and NCT. The company was founded in 2018 by Peter Steiner and Jens M. Kelm, with Jens M. Kelm serving as CEO since then. | Amministratore Delegato | - | - |
| Fondatore | 01/01/2018 | - |
Storia della carriera di Jens M. Kelm
Precedenti posizioni note di Jens M. Kelm
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Zurich | Corporate Officer/Principal | 01/12/2009 | 01/12/2009 |
Statistiche
Distribuzione geografica
| Svizzera | 4 |
Posizioni
| Founder | 2 |
| Chairman | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
InSphero AG
InSphero AG BiotechnologyHealth Technology InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland. | Health Technology |
PreComb Therapeutics AG
PreComb Therapeutics AG Pharmaceuticals: MajorHealth Technology PreComb Therapeutics AG is a Swiss company that specializes in functional precision medicine for oncology and cancer. The company is based in Hombrechtikon, Switzerland. The company uses organoid and predictive technologies, as well as AI and data mining, to guide therapy and automate processes. The company also works in immune oncology and collaborate with other organizations such as 2curex, Xilis, USZ, DKFZ, and NCT. The company was founded in 2018 by Peter Steiner and Jens M. Kelm, with Jens M. Kelm serving as CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Jens M. Kelm
- Esperienza
